I21.4

Non-ST elevation (NSTEMI) myocardial infarction

## Clinical Overview of Non-ST Elevation Myocardial Infarction (NSTEMI) Non-ST elevation myocardial infarction (NSTEMI) is a significant subset of acute coronary syndromes (ACS) characterized by myocardial necrosis (as evidenced by elevated cardiac biomarkers) without the acute ST-segment elevation typically seen in transmural infarctions (STEMI). While often considered 'less severe' than STEMI due to the absence of total occlusive thrombus, NSTEMI carries a high risk of recurrent ischemic events and long-term mortality, often occurring in patients with multi-vessel coronary artery disease. ### Pathophysiology The primary pathophysiological mechanism in NSTEMI is the rupture or erosion of a vulnerable atherosclerotic plaque. This disruption exposes the highly thrombogenic subendothelial matrix to the bloodstream, triggering platelet activation, aggregation, and the formation of a sub-occlusive thrombus. Unlike STEMI, where the thrombus is usually rich in fibrin and causes complete vessel occlusion, NSTEMI thrombi are often 'white thrombi' (platelet-rich) that allow some distal blood flow but cause critical ischemia and subendocardial necrosis. It is also classified within the 'Type 1 MI' category when related to plaque events, though NSTEMI can also occur as 'Type 2 MI' due to a supply-demand mismatch in conditions such as severe anemia, tachycardia, or hypertension. ### Diagnostic Criteria and Evaluation The diagnosis of NSTEMI is established according to the Fourth Universal Definition of Myocardial Infarction. It requires the detection of a rise and/or fall of cardiac biomarkers, preferably high-sensitivity cardiac troponin (hscTn), with at least one value exceeding the 99th percentile of the upper reference limit (URL). This biochemical evidence must be accompanied by at least one of the following: clinical symptoms of ischemia, new ischemic ECG changes (such as ST-segment depression or T-wave inversion), or imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. In the case of I21.4, the ECG must specifically lack persistent ST-segment elevation. ### Clinical Presentation and Risk Stratification Patients typically present with retrosternal chest pressure or pain (angina) that may radiate to the left arm, jaw, or neck. 'Anginal equivalents' such as dyspnea, nausea, and diaphoresis are common, particularly in elderly patients, women, or those with diabetes. Once diagnosed, risk stratification using validated tools such as the GRACE or TIMI risk scores is vital to determine the timing of invasive strategies. High-risk patients (identified by hemodynamic instability, refractory pain, or high risk scores) benefit from early coronary angiography and revascularization. ### Standard of Care and Long-term Management Acute management involves 'MONA-B' (Morphine, Oxygen, Nitroglycerin, Aspirin, and Beta-blockers) where indicated, alongside modern anticoagulation (e.g., heparin or enoxaparin) and dual antiplatelet therapy (DAPT) with Aspirin and a P2Y12 inhibitor. Long-term secondary prevention is critical and focuses on high-intensity statin therapy, ACE inhibitors or ARBs, beta-blockers, and aggressive modification of risk factors such as smoking cessation, blood pressure control, and glycemic management in diabetic patients.

Clinical Symptoms

  • Substernal chest pain or pressure
  • Radiation of pain to the jaw, neck, or left arm
  • Dyspnea (shortness of breath)
  • Diaphoresis (profuse sweating)
  • Nausea and vomiting
  • Lightheadedness or syncope
  • Palpitations
  • Profound fatigue
  • Epigastric discomfort
  • Sense of impending doom

Common Causes

  • Rupture of an atherosclerotic plaque (Type 1 MI)
  • Erosion of a coronary artery plaque
  • Coronary artery vasospasm (Prinzmetal's angina)
  • Supply-demand mismatch (Type 2 MI)
  • Spontaneous coronary artery dissection (SCAD)
  • Coronary embolism
  • Severe anemia
  • Cocaine or sympathomimetic drug use
  • Hypertensive emergency
  • Tachyarrhythmias

Documentation & Coding Tips

Explicitly distinguish between Type 1 (Spontaneous) and Type 2 (Demand) Myocardial Infarction.

Example: Patient presents with acute substernal chest pressure and elevated Troponin T of 2.45 ng/mL. EKG shows ST depressions in V4-V6. Diagnosis: Acute Type 1 NSTEMI (I21.4). Patient also has underlying ESRD on dialysis (N18.6) and morbid obesity (E66.01), both assessed as complicating factors requiring additional monitoring and contributing to high-risk medical decision making.

Billing Focus: Specifying 'Type 1' allows for the use of I21.4 rather than the less specific I21.A1.

Document the 'Age' of the infarct precisely, using 'Acute' for those occurring within 4 weeks.

Example: Follow-up of an acute NSTEMI (I21.4) occurring 10 days ago. Patient was treated with DES to the circumflex artery. Currently stable on dual antiplatelet therapy. Note also addresses chronic systolic heart failure (I50.22) which is being managed with carvedilol and lisinopril post-MI.

Billing Focus: Ensures correct use of I21.4 versus I25.2 (Old Myocardial Infarction).

Specify the coronary artery involved if known, even for NSTEMI, to provide clinical depth.

Example: Acute NSTEMI (I21.4) localized to the distribution of the Obtuse Marginal 1 branch of the Circumflex artery. EKG shows T-wave inversions. Patient has comorbid peripheral vascular disease (I73.9) and long-term tobacco use (F17.210), increasing the complexity of vascular management.

Billing Focus: Links the diagnostic code to procedural codes like PCI (92928) for specific vessels.

Ensure documentation clearly separates 'Myocardial Infarction' from 'Myocardial Injury'.

Example: Elevated troponin (0.89) noted in the setting of acute sepsis and tachycardia. This is documented as myocardial injury (I21.A1) rather than an acute NSTEMI (I21.4), as there are no ischemic symptoms or EKG changes. Patient's COPD with acute exacerbation (J44.1) is the primary driver of the demand ischemia.

Billing Focus: Prevents overcoding I21.4 when I21.A1 is clinically appropriate, avoiding audit recoupment.

Document the episode of care and whether the patient is being transferred or is at the initial facility.

Example: Initial encounter for Acute NSTEMI (I21.4) in a patient with history of CABG (Z95.1). Patient transferred to tertiary center for emergent catheterization. Also managing Hypertension Stage 2 (I10) and Hyperlipidemia (E78.5).

Billing Focus: Determines the sequence of codes and the appropriateness of high-acuity E/M codes.

Relevant CPT Codes

Related Diagnoses

Hierarchy